Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotech Gets $100M Loan to Boost Breast Cancer Drug - Los Angeles Business Journal
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Biotechnology and Bixink Therapeutics Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in South Korea | Business Wire
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet
Puma Biotechnology
PumaBiotech (@pumabiotech) / Twitter
Exhibitor Puma Biotechnology 02-20 - Scripps CME Connection
Is Puma Biotechnology a Buy? | The Motley Fool
Puma Biotechnology
Puma Biotech Strikes Deal to Develop and Market its Breast Cancer Drug in China - Los Angeles Business Journal
SEC charges former Puma biotech exec with $1.1 million in insider trading
Puma Biotechnology
Puma Biotechnology Inc
Puma Biotech shares slide after glimpse of trial data on cancer drug | Financial Times
Puma Biotechnology
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology
